
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4476538
[patent_doc_number] => 07906296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Detection of anaplasma platys'
[patent_app_type] => utility
[patent_app_number] => 12/368680
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 11735
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906296.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368680
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368680 | Detection of anaplasma platys | Feb 9, 2009 | Issued |
Array
(
[id] => 6144392
[patent_doc_number] => 20110130300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'ASSAY FOR DIAGNOSING STREPTOCOCCUS PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 12/865198
[patent_app_country] => US
[patent_app_date] => 2008-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8996
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865198 | Assay for diagnosing Streptococcus pneumoniae | Feb 1, 2009 | Issued |
Array
(
[id] => 5278005
[patent_doc_number] => 20090130137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/357853
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16974
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12357853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/357853 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Jan 21, 2009 | Issued |
Array
(
[id] => 4581674
[patent_doc_number] => 07851171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases'
[patent_app_type] => utility
[patent_app_number] => 12/351032
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8931
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/851/07851171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12351032
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351032 | Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases | Jan 8, 2009 | Issued |
Array
(
[id] => 5993830
[patent_doc_number] => 20110015377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHOD FOR PREPARING ANTIGEN EFFECTIVE FOR PREVENTING ANTHRAX INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/812176
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3824
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812176
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812176 | Method for preparing antigen effective for preventing anthrax infection | Jan 8, 2009 | Issued |
Array
(
[id] => 5264454
[patent_doc_number] => 20090117139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'LUTZOMYIA LONGIPALPIS POLYPEPTIDES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/350179
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28706
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12350179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/350179 | Lutzomyia longipalpis polypeptides and methods of use | Jan 6, 2009 | Issued |
Array
(
[id] => 6562906
[patent_doc_number] => 20100272788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'VACCINES FOR MALARIA'
[patent_app_type] => utility
[patent_app_number] => 12/810364
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9676
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272788.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810364 | Vaccines for malaria | Dec 21, 2008 | Issued |
Array
(
[id] => 91361
[patent_doc_number] => 07731978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Mutant forms of streptolysin O'
[patent_app_type] => utility
[patent_app_number] => 12/339365
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 20168
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/731/07731978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12339365
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/339365 | Mutant forms of streptolysin O | Dec 18, 2008 | Issued |
Array
(
[id] => 5502229
[patent_doc_number] => 20090162917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Subtilism Carlsberg Proteins With Reduced Immunogencity'
[patent_app_type] => utility
[patent_app_number] => 12/337358
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31585
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162917.pdf
[firstpage_image] =>[orig_patent_app_number] => 12337358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/337358 | Subtilism Carlsberg Proteins With Reduced Immunogencity | Dec 16, 2008 | Abandoned |
Array
(
[id] => 5952476
[patent_doc_number] => 20110033492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'VACCINES FOR BRUCELLOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/809685
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6973
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033492.pdf
[firstpage_image] =>[orig_patent_app_number] => 12809685
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/809685 | VACCINES FOR BRUCELLOSIS | Dec 16, 2008 | Abandoned |
Array
(
[id] => 5545387
[patent_doc_number] => 20090155264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Novel composition and methods for the treatment of psoriasis'
[patent_app_type] => utility
[patent_app_number] => 12/315978
[patent_app_country] => US
[patent_app_date] => 2008-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 38374
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155264.pdf
[firstpage_image] =>[orig_patent_app_number] => 12315978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/315978 | Novel composition and methods for the treatment of psoriasis | Dec 7, 2008 | Abandoned |
Array
(
[id] => 5545419
[patent_doc_number] => 20090155296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'MUTANTS OF LYSINE DECARBOXYLASE, VACCINES FOR PERIODONTITIS, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/329327
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11407
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155296.pdf
[firstpage_image] =>[orig_patent_app_number] => 12329327
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329327 | Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use | Dec 4, 2008 | Issued |
Array
(
[id] => 6434199
[patent_doc_number] => 20100278854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'CHLAMYDIA ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 12/746155
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20777
[patent_no_of_claims] => 188
[patent_no_of_ind_claims] => 80
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746155 | Chlamydia antigens | Dec 2, 2008 | Issued |
Array
(
[id] => 4532473
[patent_doc_number] => 07888054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Ehrlichia canis DIVA (differentiate infected from vaccinated animals)'
[patent_app_type] => utility
[patent_app_number] => 12/262709
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 32063
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888054.pdf
[firstpage_image] =>[orig_patent_app_number] => 12262709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/262709 | Ehrlichia canis DIVA (differentiate infected from vaccinated animals) | Oct 30, 2008 | Issued |
Array
(
[id] => 5975993
[patent_doc_number] => 20110070265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'ENGINEERED PERTACTIN VARIANTS FOR VACCINE USE'
[patent_app_type] => utility
[patent_app_number] => 12/739658
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5655
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12739658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739658 | Engineered pertactin variants for vaccine use | Oct 16, 2008 | Issued |
Array
(
[id] => 52725
[patent_doc_number] => 07771960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Feline pancreatic lipase'
[patent_app_type] => utility
[patent_app_number] => 12/252120
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18647
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/771/07771960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12252120
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/252120 | Feline pancreatic lipase | Oct 14, 2008 | Issued |
Array
(
[id] => 8870379
[patent_doc_number] => 08465755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Recombinant bacterium capable of eliciting an immune response against enteric pathogens'
[patent_app_type] => utility
[patent_app_number] => 12/681721
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 47
[patent_no_of_words] => 32550
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681721 | Recombinant bacterium capable of eliciting an immune response against enteric pathogens | Oct 5, 2008 | Issued |
Array
(
[id] => 8875596
[patent_doc_number] => 08470560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/680758
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 21611
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680758 | CR-2 binding peptide P28 as molecular adjuvant for DNA vaccines | Oct 2, 2008 | Issued |
Array
(
[id] => 5501691
[patent_doc_number] => 20090162379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/286586
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5164
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162379.pdf
[firstpage_image] =>[orig_patent_app_number] => 12286586
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286586 | Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor | Sep 30, 2008 | Abandoned |
Array
(
[id] => 4570843
[patent_doc_number] => 07824692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Ehrlichia disulfide bond formation proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/242865
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 9578
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12242865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/242865 | Ehrlichia disulfide bond formation proteins and uses thereof | Sep 29, 2008 | Issued |